Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Alizyme issued BTG license option

June 28, 1996

Hoechst, Hoechst Marion Roussel and Oncogene Science extend collaboration

June 28, 1996

Oxford Molecular Group and Alizyme begin research collaboration

June 28, 1996

Boston Life Science holds patent rights to C-Maf

June 28, 1996

3-D IMP dehydrogenase structure solved

June 28, 1996

Gensia receives first payment from Pfizer

June 28, 1996

Ciba-Geigy and Synaptic extend collaboration

June 28, 1996

Competitive Technologies and Mount Sinai School of Medicine sign agreement

June 21, 1996

Cheung Laboratories and MIT reach marketing agreement

June 21, 1996

Zeneca to utilize Incyte database and technologies

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...